Concomitant chemoradiation versus radical radiotherapy in advanced squamous cell carcinoma of oropharynx and nasopharynx using weekly cisplatin: a phase II randomized trial-Reference-Cited by-同舟云学术

Concomitant chemoradiation versus radical radiotherapy in advanced squamous cell carcinoma of oropharynx and nasopharynx using weekly cisplatin: a phase II randomized trial

Published:2010-11 Issue:11 Volume:21 Page:2272-2277
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Sharma A.,Mohanti B.K.,Thakar A.,Bahadur S.,Bhasker S.

Funder

All India Institute of Medical Sciences

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/21/11/2272/572219/mdq219.pdf

Reference18 articles.

1. Commentary: head and neck carcinomas in the developing world;Wei;Br Med J,2002

2. Cancer Incidence, Mortality and Prevalence Worldwide;Globocan 2002,2001

3. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer;Pignon;Lancet,2000

4. Systemic chemotherapy for squamous cell head and neck cancer;Adelstein;Expert Opin Pharmacother,2003

5. Meta-analyses of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomized trials and 17,346 patients;Pignon;Radiother Oncol,2009

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Standard versus fractionated high-dose cisplatin plus radiation for locally advanced head and neck cancer: Results of the CisFRad (GORTEC 2015-02) randomized phase II trial;Radiotherapy and Oncology;2024-08

2. Dose-escalated re-irradiation improves outcome in locally recurrent head and neck cancer – Results of a large multicenter analysis;Radiotherapy and Oncology;2023-04

3. A rare case of peritoneal metastases from oropharyngeal squamous cell carcinoma in a young male after completion of chemoradiotherapy;Journal of Cancer Research and Therapeutics;2023

4. Concurrent chemoradiotherapy with cisplatin given once-a-week versus every-three weekly in head and neck squamous cell carcinoma: Non-inferior, equivalent, or superior?;Oral Oncology;2022-11

5. Weekly Cisplatin Plus Radiation for Postoperative Head and Neck Cancer (JCOG1008): A Multicenter, Noninferiority, Phase II/III Randomized Controlled Trial;Journal of Clinical Oncology;2022-06-20